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Abstract: 
Background: Clinical laboratories are critical to correct diagnosis of medical conditions to ensure appropriate 
management. Point prevalence survey (PPS) of antimicrobial use and resistance performed in Nigeria in 2015 and 
2017 showed high rates of antibiotic use, but poor laboratory utilization for definitive diagnosis of the infections for 
which the antimicrobials were prescribed. This study investigated the reasons for clinicians‟ poor utilization of the 
clinical laboratory for definitive diagnosis and treatment of infections.                     
Methods: A cross sectional survey of clinicians attending the 2018 annual scientific conference and general 
meeting of the National Postgraduate Medical College of Nigeria (NPMCN) in Owerri, Southeastern Nigeria, was 
conducted using self-administered structured questionnaire to obtain information on the sub-optimal utilization of 
the clinical microbiology laboratory.                                
Results: Of 283 respondents, 14.8% were general practitioners and 85.2% were specialists who have been in 
practice for a median period of 20 years (range 3 – 48 years). The specialists included surgeons (26%), family 
physicians (19.8%), internists (14.3%), pathologists (13.9%), paediatricians (8.8%), obstetricians and 
gynecologists (8.1%), community medicine physicians (6.2%), and dental surgeons (2.6%). Majority of the 
respondents (90.8%) work in public, 88.3% work in tertiary and 9.9% in secondary care hospitals. For diagnosis of 
infections, 16% and 49.8% reported using laboratory “always” and “very often” respectively. Among these, the 
most commonly utilized investigations were microscopy, culture and sensitivity (62.4%), DNA detection (18.3%), 
GeneXpert for tuberculosis (17.2%), and antigen detection (16.7%). Among clinicians that “hardly make use” of 
the laboratory, their reasons for non-use were; clinical diagnosis being sufficient (39.7%), delayed results (17.2%), 
having knowledge of „potent‟ antibiotics (15.5%), lack of access to microbiology laboratory (13.8%), absence of 
pathologists to assure quality of tests (12.1%), and no need of the laboratory to manage patients with infections 
(8.6%).                              
Conclusion: These findings indicate that poor use of the microbiology laboratory seems mainly associated with 
perception and attitude of the physicians to the relevance of the laboratory, and perceived inadequacy of 
microbiology practice in some others. There is need to raise physicians‟ awareness on the relevance and what 
constitutes optimal use of the clinical microbiology laboratory for accurate diagnosis of infections and appropriate 
antimicrobial use. 
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Abstrait: 
Contexte: Les laboratoires cliniques sont essentiels pour corriger le diagnostic des conditions médicales et assurer 
une prise en charge appropriée. Une enquête de prévalence ponctuelle (PPS) sur l'utilisation et la résistance aux 
antimicrobiens réalisée au Nigéria en 2015 et 2017 a montré des taux élevés d'utilisation d'antibiotiques, mais une 
faible utilisation en laboratoire pour le diagnostic définitif des infections pour lesquelles les antimicrobiens ont été 
prescrits. Cette étude a examiné les raisons de la faible utilisation du laboratoire par les cliniciens pour le 
diagnostic définitif et le traitement des infections.                          
Méthodes: Une enquête transversale sur les cliniciens participant à la conférence scientifique annuelle et à 
l'assemblée générale de 2018 du Collège national des médecins diplômés du Nigéria (NPMCN) à Owerri, dans le 
sud-est du Nigéria, a été réalisée à l'aide d'un questionnaire structuré auto-administré visant à obtenir des 
informations sur le sous-optimal. utilisation du laboratoire de microbiologie clinique.                                       
Résultats: Sur 283 répondants, 14,8% étaient des omnipraticiens et 85,2% des spécialistes exerçant depuis 20 
ans en moyenne (de 3 à 48 ans). Les spécialistes comprenaient des chirurgiens (26%), des médecins de famille 
(19,8%), des internistes (14,3%), des pathologistes (13,9%), des pédiatres (8,8%), des obstétriciens et des 
gynécologues (8,1%), des médecins de santé communautaires (6,2%), et chirurgiens dentistes (2,6%). La 
majorité des répondants (90,8%) travaillent en public, 88,3% dans le tertiaire et 9,9% dans les hôpitaux de soins 
secondaires. Pour le diagnostic des infections, 16% et 49,8% ont déclaré utiliser le laboratoire «toujours» et «très 
souvent» respectivement. Parmi ceux-ci, les examens les plus couramment utilisés étaient la microscopie, la 
culture et la sensibilité (62,4%), la détection de l'ADN (18,3%), GeneXpert pour la tuberculose (17,2%) et la 
détection de l'antigène (16,7%). Parmi les cliniciens qui «utilisent à peine» le laboratoire, les raisons de leur non-
utilisation étaient: diagnostic clinique suffisant (39,7%), résultats tardifs (17,2%), connaissance d'antibiotiques 
«puissants» (15,5%), manque d'accès au laboratoire de microbiologie (13,8%), absence de pathologistes pour 
garantir la qualité des tests (12,1% ), et aucun laboratoire n‟a besoin de prendre en charge des patients infectés 
(8,6%).                                            
Conclusion: Ces résultats indiquent que la mauvaise utilisation du laboratoire de microbiologie semble 
principalement associée à la perception et à l'attitude des médecins à l'égard de la pertinence du laboratoire, et à 
l'insuffisance perçue de la pratique de la microbiologie chez certains autres. Il est nécessaire de sensibiliser les 
médecins à la pertinence et à l'utilisation optimale du laboratoire de microbiologie clinique pour un diagnostic précis 
des infections et une utilisation appropriée des antimicrobiens. 
Mots-clés: utilisation, laboratoire de microbiologie, diagnostic, antimicrobiens, maladies infectieuses 
Introduction:  
Antimicrobial resistance is increasing 
globally and locally (1,2,3). Multidrug resistant 
organisms have been isolated from clinical and 
environmental sources in different parts of 
Nigeria and their rates are on the increase 
(3,4,5). Rational antibiotic use is needed to 
reduce selection pressure on bacteria and curb 
development of antibiotic resistance. This 
involves use of antibiotic policy and guidelines 
for antibiotic prescriptions. To produce a 
meaningful antibiotics guideline, locally gene- 
rated data on the antibiogram of the prevailing 
pathogenic bacteria in an area are recom- 
mended (6). Targeted antimicrobial therapy, 
as recommended by antimicrobial stewardship, 
is one of the ways to achieve rational antibiotic 
use (7). This involves the identification and 
determination of antimicrobial susceptibility 
pattern of the offending pathogens.   
 Antibiotic guideline and targeted anti- 
microbial therapy require the utilization of the 
clinical microbiology laboratory. To optimize 
accurate diagnosis of infectious diseases, 
clinicians need to ensure that diagnostic 




specimens are properly collected, transported 
and promptly submitted to the clinical 
microbiology laboratory, preferably before the 
initiation of antimicrobial therapy (8). Even in 
life-threatening conditions such as sepsis and 
septic shock where prompt initial antibiotic 
therapy is associated with better outcome, it is 
still recommended that blood culture samples 
be obtained before initiation of antibiotic 
treatment, though without delaying the latter. 
 Many infectious conditions hardly 
require instant antimicrobial administration, 
therefore, the time spent for proper diagnosis 
and prudent selection of antibiotics will be of 
great benefit to the patient and the health care 
system in the long run. Biomarkers such as 
procalcitonin and C-reactive protein levels are 
usually employed to guide empiric antibiotic 
therapy, which is usually broad spectrum or 
involves combination therapy. Treatment may 
need to be de-escalated and the antibiotic 
spectrum narrowed as soon as culture and 
susceptibility pattern are ascertained. This 
reduces the incidence of adverse events and 
cost, as well as delay the emergence of 
antimicrobial resistance.   
 Point prevalence survey (PPS) of anti- 
microbial prescription and resistance conducted 
in Nigeria in 2015 and 2017 showed very high 
rates of antibiotic use and poor laboratory 
utilization for definitive diagnosis of infections 
for which the antimicrobials were prescribed 
(9,10). These findings raised the question as to 
why clinicians are not optimally utilizing the 
clinical microbiology laboratory. The objective 
of this study was therefore to determine the 
reasons for clinicians‟ suboptimal utilization of 
the clinical microbiology laboratory in Nigeria 
for diagnosis of infections. 
Materials and method:  
Study setting      
 The study setting is Nigeria which 
operates a three-tiered hierarchical health 
structure; primary, secondary and tertiary 
health facilities (11). Each tier is manned by 
certain categories of health manpower that 
render specified range of services to the public. 
Irrespective of the tier, the health facility could 
be publicly or privately funded. The secondary 
and tertiary health facilities are more likely to 
have full laboratory support compared to the 
primary health facilities. Health facilities 
without laboratory support often depend on the 
privately-owned laboratory facilities. Most of 
the specialists practice in the secondary and 
tertiary health facilities.   
Study design, population and sample size  
 We conducted a descriptive cross-
sectional survey of specialists attending the 
annual scientific conference and general 
meeting of the National Postgraduate Medical 
College of Nigeria (NPMCN) in Owerri, South- 
eastern Nigeria, in August 2018. The NPMCN 
has trained over 7,000 specialists, with about 
4,000 currently practicing in Nigeria. The 
conference was attended by 800 delegates 
(personal communication).   
 The sample size was calculated using 
the formula for estimating single independent 
proportion (12). We assumed 50% utilization 
of laboratory services and 5% level of 
significance. We also adjusted for a population 
less than 10,000 and 75% response rate. This 
gave us the sample size of 468, which was 
approximated to 470.  
Sampling technique and data collection 
 We used a semi-structured pre-tested 
questionnaire to collect information on socio-
demographic characteristics, use of clinical 
microbiology laboratory for diagnosis of 
infections, and reasons for non-use of the 
laboratory, from each participant. The 
participants from different specialties were 
selected by ballot without replacement method 
of simple random sampling technique, and the 
questionnaires were hand-delivered to and 
self-administered by each participant.  
 The degree of utilization of the clinical 
microbiology laboratory services was ranked as 
„always‟, „very often‟, „occasionally‟, „not often‟, 
„rarely‟ and „never‟. Responses of „always‟ and 
„very often‟ were categorized as „good use‟ 
while others were categorized as „poor use‟ of 
the laboratory.  
Data analysis      
 Data were analyzed using EPI INFO 
version 7.2 (US CDC). The socio-demographic 
characteristics and the degree of use of clinical 
microbiology laboratory were presented as 
frequency and proportions. The relationship 
between use of clinical microbiology laboratory 
and socio-demographic characteristics were 
examined using Chi square test at 5% level of 
significance. The odd ratio and 95% confidence 
interval of the odds were estimated.                     
Results:  
 Only 283 participants returned comp- 
leted questionnaires giving a response rate of 
60.2%. There were 207 (73.1%) males, with 
male: female ratio of 2.7:1. The age group 45- 




49years constituted the largest group (25.2%). 
Forty-two (14.8%) respondents were general 
practitioners while 241 (85.2%) were specia- 
lists who have been in practice for a median 
period of 20 years (3–48years). The specialists 
included general surgeons (26%), family 
physicians (19.8%), internists (14.3%), 
pathologists (13.9%), paediatricians (8.8%),    
obstetricians and gynecologists (8.1%), comm- 
unity medicine physicians (6.2%), and dental 
surgeons (2.6%) (Table 1). Majority of the 
respondents (90.8%, n=257) work in public 
hospitals, 250 (88.3%) work in tertiary and 28 
(9.9%) in secondary care hospitals  
 One hundred and eighty six (65.7%) of 
the respondents made good use of the 
laboratory; 45 (15.9%) always and 141 
(49.8%) very often, while 97 (34.3%) made 
use of the laboratory poorly; 35 (12.4%) use 
the facility occasionally, 39 (13.8%) not often, 
18 (6.3%) rarely, and 5 (1.8%) never (Table 
2). The reasons for utilization were 
microscopy, culture and sensitivity (62.4%), 
nucleic acid detection (18.3%), GeneXpert 
(17.2%) and antigen detection (16.7%) (Table 
2). Nucleic acid detection was used mainly for 
follow up for hepatitis B management.  
 Reliance on clinical diagnosis (39.7%) 
and perceived patient‟s inability to afford the 
cost of the laboratory test were the most 
common reasons given by the respondents for 
non-use of the laboratory. Others were the 
prolonged turnaround time, lack of access to 
medical microbiology laboratory, and having 
knowledge of potent antibiotics (Table 2). None 
of the factors examined was significantly 
associated with good use of the clinical 
microbiology laboratory for diagnostic purposes 
(Table 3). 
 
Table 1: Socio-demographic characteristics of respondents 
Variable Frequency Percentage (%) 
Gender   
 Male 207 73.1 
 Female 76 26.9 
Age group (years)*   
 35-39 17 6.0 
 40-44 51 18.1 
 45-49 71 25.2 
 50-54 54 19.2 
 55-59 42 14.9 
 60-64 28 9.9 
 ≥65 19 6.7 
Mean age ± SD 50.7±8.4  
Branch of Medicine   
 Physician 177 62.5 
 Surgeon 106 37.5 
General Practitioner   
 Yes 42 14.9 
 No 241 85.1 
Specialty*   
 General Surgeon 72 26.4 
 Family Physician 54 19.8 
 Internist 39 14.3 
 Pathologist 38 13.9 
 Paediatrician 24 8.8 
 Obstetrics & Gynaecologist 22 8.1 
 Community Physician 17 6.2 
 Dental Surgeon 7 2.6 
Place of Practice   
 Public 257 90.8 
 Private 15 5.3 
 Faith based 11 3.9 
Level of practice   
 Tertiary 250 88.3 
 Secondary 28 9.9 
 Primary 5 1.8 
Duration of practice (years)   
 1-10 29 10.3 
 11-20 122 43.1 
 21-30 64 22.6 
 >30 68 24.0 
*missing values 
  




Table 2: Patterns of utilization of clinical microbiology laboratory by clinicians for patient management 
Variable Frequency Percentage (%) 
Use of microbiology laboratory for diagnosis of infections (n = 283)   
 Always 45 15.9 
 Very often 141 49.8 
 Occasionally 35 12.4 
 Not often 39 13.8 
  Rarely  18 6.3 
   Never 5 1.8 
Laboratory investigations often requested for (n = 186) *   
 Bacteria culture and susceptibility tests 116 62.4 
  Nucleic acid detection  34 18.3 
  GeneXpert 32 17.2 
   Antigen detection 31 16.7 
   Microscopy 4 2.2 
   Others 59 31.7 
Nucleic acid detection (n = 34)   
   Hepatitis B 7 20.6 
   Paternity dispute 2 5.9 
   TB MDR 2 5.9 
   Sex determination  1 2.9 
   Hepatitis C 1 2.9 
Reasons for non-use of laboratory for diagnosis of infections (n = 58) *   
 Clinical diagnosis is sufficient 23 39.7 
   Patients cannot afford the cost 12 20.7 
  Results are always delayed so irrelevant to patient management 10 17.2 
   Already know potent antibiotics and no need for test 9 15.5 
   No access to medical microbiology laboratory 8 13.8 
   No pathologist to ensure quality of test 7 12.1 
    I don‟t need lab to manage patients with infections 5 8.6 
 Others 19 32.8 
*Multiple responses allowed 
Table 3: Factors associated with laboratory utilization by clinicians 
Variable 
Laboratory utilization Crude Odds ratio 
(95% CI) Good (%) Poor (%) 
Gender    
 Male 137 (66.2) 70 (33.8) 1.1 (0.62-1.87) 
 Female 49 (64.5) 27 (35.5) 1 
General Practitioner    
 Yes 28 (66.7) 14 (33.3) 1.1 (0.53-2.11) 
 No 157 (65.4) 83 (34.6) 1 
Branch of Medicine    
 Physicians 117 (66.1) 60 (33.9) 1.0 (0.63-1.93) 
 Surgeons 69 (65.1) 37 (34.9) 1 
Level of Practice    
 Tertiary 164 (65.6) 86 (34.4) 1.0 (0.44-2.05) 
 Others 22 (66.7) 11 (33.3) 1 
Duration of Practice (years)    
 1 – 10 16 (55.2) 13 (44.8) 0.6 (0.26-1.56) 
 11 – 20 77 (63.1) 45 (36.9) 0.9 (0.49-1.69) 
 21 – 30 48 (75.0) 16 (25.0) 1.6 (0.73-3.35) 




 This study revealed suboptimal use of 
the clinical microbiology laboratory, contrary to 
the practice in western countries where studies 
have shown that there is over utilization of the 
clinical laboratories and efforts are actually 
being made to reduce this (13,14,15). The 
clinical microbiology laboratory plays a vital 
role in the management of infectious diseases. 
Non utilization of the laboratory has dire 
consequences as diagnosis of infectious 
diseases based on symptoms and signs lead to 
both over and under-diagnosis or outright 




misdiagnosis of some infections. These have 
clinical implications including over and 
inappropriate prescription of antibiotics, 
wastages, infection complications, economic 
consequences, and potential fatal outcome 
(10,16,17,18).    
 One of the reasons for non-use of the 
clinical laboratory by physicians in this survey 
is the presumed sufficiency of clinical 
diagnosis, thereby making microbiology invest- 
igations unnecessary. Similar findings have 
been reported in other African countries where 
doctors express doubt about accuracy of 
laboratory results or are confused by them and 
therefore prefer to follow up patients rather 
than use the laboratory (19,20,21,22). In 
these countries, poor laboratory infrastructure 
or personnel have been blamed for this, but in 
our study, respondents who work in reputable 
tertiary hospitals with good clinical micro- 
biology laboratories and qualified pathologists 
did not make effective use of the laboratories 
(19,20,21,22).     
 Some of the respondents claim to 
already have knowledge of potent antibiotics 
and therefore do not require the laboratory. 
This view may be the result of lack of 
knowledge of the critical role clinical 
microbiology laboratory plays in the diagnosis 
and treatment of infectious diseases, as well as 
low awareness and/or absence of antimicrobial 
stewardship programmes in most Nigerian 
hospitals at the time of the survey. This may 
be responsible for high use of antibiotics noted 
in some surveys (9,10,23,24). The obvious 
lack of association between poor clinical 
microbiology utilization and any of the 
sociodemographic variables analysed highly 
suggests that poor clinical microbiology 
laboratory utilization is a habit or behavioural 
anomaly that cuts across the spectrum of 
doctors.     
 The low utilization of nucleic acid 
detection tests suggests possibility of poor 
diagnosis of viral infections. This is a cause for 
concern as a significant proportion of viral 
infections are often mistreated with antibiotics 
thus paving way for subsequent development 
of antimicrobial resistance. Previous studies 
have reported over prescribing of antibiotics 
for viral diseases (25).   
 One limitation of the study was the use 
of subjective adjectives in describing the 
degree of laboratory utilization. The study 
participants were specialists whom we believed 
have good understanding of the words and 
were honest in their responses. However, in 
view of the very low rate targeted antibiotic 
therapy obtained in previously performed 
surveys, the rate of non-use of the micro- 
biology laboratory confessed may well be an 
underestimate and need to be corroborated 
with other studies (9,10). Another limitation 
may be the high level of non response rate 
that is typical of such settings.  
Conclusion: 
 The results of this study confirm that 
physicians‟ use of the clinical microbiology 
laboratory in Nigeria for diagnosis of infection 
is suboptimal and needs to be improved on. 
The reasons for these are mainly physicians‟ 
perception that clinical diagnosis is sufficient, 
delayed laboratory results, poor access to 
microbiology laboratory, and lack of qualified 
pathologists. There is urgent need for 
education of physicians to optimally utilize the 
microbiology laboratory to improve their 
antibiotics prescribing practice, and also the 
need to raise awareness among them on what 
constitutes optimal use of the laboratory for 
diagnosis and appropriate management of 
infections. 
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